Left atrial appendage closure: prevalence and risk of device-associated thrombus formation.
作者信息
Bertog Stefan, Sievert Horst
机构信息
CardioVascular Center Frankfurt, Frankfurt, Germany.
Minneapolis Veterans Affairs Medical Center, Minneapolis, USA.
出版信息
Cardiovasc Diagn Ther. 2019 Feb;9(1):104-109. doi: 10.21037/cdt.2018.10.05.
Abstract
摘要
相似文献
1
Left atrial appendage closure: prevalence and risk of device-associated thrombus formation.
Cardiovasc Diagn Ther. 2019 Feb;9(1):104-109. doi: 10.21037/cdt.2018.10.05.
2
Extending percutaneous left atrial appendage closure indications using the AMPLATZER™ Cardiac Plug device in patients with persistent left atrial appendage thrombus: The thrombus trapping technique.
Arch Cardiovasc Dis. 2016 Dec;109(12):659-666. doi: 10.1016/j.acvd.2016.02.012. Epub 2016 Jul 8.
3
Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes.
Circulation. 2018 Aug 28;138(9):874-885. doi: 10.1161/CIRCULATIONAHA.118.035090.
4
Incidence, Characteristics, and Clinical Course of Device-Related Thrombus After Watchman Left Atrial Appendage Occlusion Device Implantation in Atrial Fibrillation Patients.
JACC Clin Electrophysiol. 2017 Dec 11;3(12):1380-1386. doi: 10.1016/j.jacep.2017.05.006. Epub 2017 Aug 2.
5
Device-Related Thrombosis After Percutaneous Left Atrial Appendage Occlusion for Atrial Fibrillation.
J Am Coll Cardiol. 2018 Apr 10;71(14):1528-1536. doi: 10.1016/j.jacc.2018.01.076.
6
Left atrial appendage closure: outcomes and challenges.
Neth Heart J. 2017 Feb;25(2):143-151. doi: 10.1007/s12471-016-0929-0.
7
Left atrial appendage function and thrombus formation in atrial fibrillation-flutter: a transesophageal echocardiographic study.
J Am Coll Cardiol. 1994 Jul;24(1):159-64. doi: 10.1016/0735-1097(94)90557-6.
8
Feasibility and clinical efficacy of left atrial ablation for the treatment of atrial tachyarrhythmias in patients with left atrial appendage closure devices.
Heart Rhythm. 2015 Jul;12(7):1524-31. doi: 10.1016/j.hrthm.2015.03.011. Epub 2015 Mar 10.
9
Anatomy and Physiologic Roles of the Left Atrial Appendage: Implications for Endocardial and Epicardial Device Closure.
Interv Cardiol Clin. 2018 Apr;7(2):185-199. doi: 10.1016/j.iccl.2017.12.001.
10
Device-Related Thrombus After Left Atrial Appendage Closure.
Interv Cardiol. 2019 Feb;14(1):42-44. doi: 10.15420/icr.2018.21.3.
引用本文的文献
1
An updated meta-analysis of device related thrombus following left atrial appendage closure in patients with atrial fibrillation.
Front Cardiovasc Med. 2022 Dec 23;9:1088782. doi: 10.3389/fcvm.2022.1088782. eCollection 2022.
2
Outcomes of cardiac surgery with left atrial appendage occlusion versus no Occlusion, direct oral Anticoagulants, and vitamin K Antagonists: A systematic review with Meta-analysis.
Int J Cardiol Heart Vasc. 2022 Apr 26;40:100998. doi: 10.1016/j.ijcha.2022.100998. eCollection 2022 Jun.
本文引用的文献
1
Reply: Device-Related Thrombus After Percutaneous Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation.
J Am Coll Cardiol. 2018 Jul 24;72(4):474-475. doi: 10.1016/j.jacc.2018.05.028.
2
Prevalence of left atrial appendage thrombus detected by transoesophageal echocardiography before catheter ablation of atrial fibrillation in patients anticoagulated with non-vitamin K antagonist oral anticoagulants.
Europace. 2019 Jan 1;21(1):48-53. doi: 10.1093/europace/euy129.
3
Prevalence of Left Atrial Thrombus Detection by Transesophageal Echocardiography: A Comparison of Continuous Non-Vitamin K Antagonist Oral Anticoagulant Versus Warfarin Therapy in Patients Undergoing Catheter Ablation for Atrial Fibrillation.
JACC Clin Electrophysiol. 2016 Jun;2(3):295-303. doi: 10.1016/j.jacep.2016.01.004. Epub 2016 Mar 23.
4
Occurrence of Incomplete Endothelialization Causing Residual Permeability After Left Atrial Appendage Closure.
J Invasive Cardiol. 2018 Jul;30(7):245-250. Epub 2018 May 15.
5
Extensive Endothelialization or Thrombus Related to New-Generation Left Atrial Appendage Occluders.
JACC Clin Electrophysiol. 2017 Jul;3(7):787-788. doi: 10.1016/j.jacep.2016.12.021. Epub 2017 Mar 29.
6
Trends in Transesophageal Echocardiography Use, Findings, and Clinical Outcomes in the Era of Minimally Interrupted Anticoagulation for Atrial Fibrillation Ablation.
JACC Clin Electrophysiol. 2017 Apr;3(4):329-336. doi: 10.1016/j.jacep.2016.09.011. Epub 2016 Nov 23.
7
Is von Willebrand factor associated with stroke and death at mid-term in patients with non-valvular atrial fibrillation?
Arch Cardiovasc Dis. 2018 May;111(5):357-369. doi: 10.1016/j.acvd.2017.08.004.
8
Real-world safety and efficacy of WATCHMAN LAA closure at one year in patients on dual antiplatelet therapy: results of the DAPT subgroup from the EWOLUTION all-comers study.
EuroIntervention. 2018 Apr 20;13(17):2003-2011. doi: 10.4244/EIJ-D-17-00672.
9
5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.
J Am Coll Cardiol. 2017 Dec 19;70(24):2964-2975. doi: 10.1016/j.jacc.2017.10.021. Epub 2017 Nov 4.
10
Safety and efficacy of early anticoagulation drug regimens after WATCHMAN left atrial appendage closure: three-month data from the EWOLUTION prospective, multicentre, monitored international WATCHMAN LAA closure registry.
EuroIntervention. 2017 Sep 20;13(7):877-884. doi: 10.4244/EIJ-D-17-00042.
Zotero 插件